Eledon Pharmaceuticals Inc
Research Eledon Pharmaceuticals Inc (ELDN) on Bullrun: market cap USD 299.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerELDN
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 299.49M
- Financial periodFY2025
- Net income-USD 45.62M
Valuation Snapshot
latest market cap is USD 299.49M.
About Eledon Pharmaceuticals Inc
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential.
Frequently asked questions
What is Eledon Pharmaceuticals Inc's market cap?
Eledon Pharmaceuticals Inc's market capitalization is USD 299.49M.
What does Eledon Pharmaceuticals Inc do?
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS).